Phase I dose escalation study of DPPG2-TSL-DOX combined with hyperthermia in soft tissue sarcoma

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507836-19-00

Acronym

TS-DM-STS-101

Enrollment

Registered

2024-09-20

Start date

2023-04-03

Completion date

2025-05-28

Last updated

2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally advanced (unresectable) or metastatic soft tissue sarcoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026